Lupus Nephritis in the Era of Biomarkers
作者： Jose Manuel Monroy Trujillo , Derek Michael Fine
DOI: 10.2215/CJN.12371115
关键词:
摘要: Renal biopsy remains the standard of care for evaluation suspected flares in lupus nephritis ([1][1]) and is generally indicated when proteinuria, active urine sediment, or elevated serum creatinine present. By time that a patient presents with these features, injury induced by
asnjournals.org
elsevier.com参考文章(10)
Brad H. Rovin, Samir V. Parikh, Anthony Alvarado, The kidney biopsy in lupus nephritis: is it still relevant? Rheumatic Diseases Clinics of North America. ,vol. 40, pp. 537- 552 ,(2014) , 10.1016/J.RDC.2014.04.004
Morgan Grams, Harold I. Feldman, Ramachandran S. Vasan, Paul L. Kimmel, Chi-yuan Hsu, Kathleen D. Liu, , Meredith C. Foster, Josef Coresh, Joseph V. Bonventre, Venkata S. Sabbisetti, Sushrut S. Waikar, Theodore E. Mifflin, Robert G. Nelson, Urinary Biomarkers and Risk of ESRD in the Atherosclerosis Risk in Communities Study Clinical Journal of The American Society of Nephrology. ,vol. 10, pp. 1956- 1963 ,(2015) , 10.2215/CJN.02590315
A-M Orbai, L Truedsson, G Sturfelt, O Nived, H Fang, G S Alarcón, C Gordon, JT Merrill, P R Fortin, I N Bruce, D A Isenberg, D J Wallace, R Ramsey-Goldman, S-C Bae, J G Hanly, J Sanchez-Guerrero, A E Clarke, C B Aranow, S Manzi, M B Urowitz, D D Gladman, K C Kalunian, M I Costner, V P Werth, A Zoma, S Bernatsky, G Ruiz-Irastorza, M A Khamashta, S Jacobsen, J P Buyon, P Maddison, M A Dooley, R F Van Vollenhoven, E Ginzler, T Stoll, C Peschken, J L Jorizzo, J P Callen, S S Lim, B J Fessler, M Inanc, D L Kamen, A Rahman, K Steinsson, A G Franks, L Sigler, S Hameed, N Pham, R Brey, M H Weisman, G McGwin, L S Magder, M Petri, Anti-C1q Antibodies in Systemic Lupus Erythematosus Lupus. ,vol. 24, pp. 42- 49 ,(2015) , 10.1177/0961203314547791
TK Chen, MM Estrella, DM Fine, Predictors of kidney biopsy complication among patients with systemic lupus erythematosus Lupus. ,vol. 21, pp. 848- 854 ,(2012) , 10.1177/0961203312439334
Chau-Ching Liu, Susan Manzi, Joseph M Ahearn, Biomarkers for systemic lupus erythematosus: a review and perspective Current Opinion in Rheumatology. ,vol. 17, pp. 543- 549 ,(2005) , 10.1097/01.BOR.0000174182.70159.22
Hermine I. Brunner, Michael R. Bennett, Rina Mina, Michiko Suzuki, Michelle Petri, Adnan N. Kiani, Joshua Pendl, David Witte, Jun Ying, Brad H. Rovin, Prasad Devarajan, Association of noninvasively measured renal protein biomarkers with histologic features of lupus nephritis. Arthritis & Rheumatism. ,vol. 64, pp. 2687- 2697 ,(2012) , 10.1002/ART.34426
Giovanna Giannico, Agnes B. Fogo, Lupus Nephritis: Is the Kidney Biopsy Currently Necessary in the Management of Lupus Nephritis? Clinical Journal of The American Society of Nephrology. ,vol. 8, pp. 138- 145 ,(2013) , 10.2215/CJN.03400412
Brad H. Rovin, Huijuan Song, Dan J. Birmingham, Lee A. Hebert, Chack Yung Yu, Haikady N. Nagaraja, Urine Chemokines as Biomarkers of Human Systemic Lupus Erythematosus Activity Journal of The American Society of Nephrology. ,vol. 16, pp. 467- 473 ,(2005) , 10.1681/ASN.2004080658
Eric A.J. Hoste, Peter A. McCullough, Kianoush Kashani, Lakhmir S. Chawla, Michael Joannidis, Andrew D. Shaw, Thorsten Feldkamp, Denise L. Uettwiller-Geiger, Paul McCarthy, Jing Shi, Michael G. Walker, John A. Kellum, Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers Nephrology Dialysis Transplantation. ,vol. 29, pp. 2054- 2061 ,(2014) , 10.1093/NDT/GFU292
Daniel J. Birmingham, Joshua E. Bitter, Ezinne G. Ndukwe, Sarah Dials, Terese R. Gullo, Sara Conroy, Haikady N. Nagaraja, Brad H. Rovin, Lee A. Hebert, Relationship of Circulating Anti-C3b and Anti-C1q IgG to Lupus Nephritis and Its Flare Clinical Journal of The American Society of Nephrology. ,vol. 11, pp. 47- 53 ,(2016) , 10.2215/CJN.03990415